Chamber and committees

We are currently engaging with the UK Government on plans to implement the Electricity Networks Commissioner’s recommendations and will update local authorities and Heads of Planning Scotland at the appropriate stage.

The 25-year contract for HMP Kilmarnock under the Private Finance Initiative (PFI) for a privately constructed and operationally managed prison expires on 16 March 2024. The decision to bring HMP Kilmarnock into public management and ownership and not to tender for a new private contract was taken in 2021. This is in line with Scottish Government policy that prisons should be owned and managed by the public sector, which has been in place since 2007.

The cost of private sector prison contracts depend on the market conditions at that particular point in time and in order to establish the cost of a new private sector contract for HMP Kilmarnock from 2024 this would have to be put out to tender. In line with Government’s long-running policy on private prisons the decision was made not to put it out to tender.

SPS is working to agree proposals for a transitional operating model, and a target operating model, which is to be adopted within the first year of the prison transferring to the public sector.

The Scottish Government does not hold the information requested. The data we receive from Police Scotland’s Criminal History System for production of the Criminal Proceedings in Scotland National Statistics bulletin includes a prosecuted person’s age and sex, but not their profession or details of the context of their case, aside from the main charge, any aggravation(s), the verdict and (if convicted) the sentence given.

Possible reform to homicide law is currently being considered by the Scottish Law Commission. In paragraph 1.27 of the Scottish Law Commission's Homicide Project Discussion paper , it is indicated corporate homicide is one of a number of topics that the Commission will not be considering as part of their project. As paragraph 1.27 and associated footnotes indicates, this is because a Members' Bill was presented to the Scottish Parliament in 2020 in this area of law and the Presiding Officer of the Scottish Parliament made a statement that the Bill was not within the legislative competence of the Parliament.

Within this context, the Scottish Government is not considering any potential reforms to corporate criminal liability with responsibility for any such reform falling to the UK Government.

In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly licensed medicines. The SMC has a transparent and robust process that is fully described on its website. It is worth noting that any SMC appraisal is undertaken independently of Scottish Ministers and is based on the clinical and cost-effectiveness of a medicine at a population level.

The SMC’s process allows companies to present a cost-effectiveness case which sets out the predicted health benefits of their treatment (including one-off treatments) over a person’s lifetime, and the SMC’s assessments follow standard methodology for such calculations. In addition, in the assessment of innovative medicines for rare conditions (including gene-edited precision medicines where a single treatment may have lifelong benefit), the SMC process involves additional flexibilities as outlined on its website. By way of an example, in 2021, the SMC was the first health technology appraisal body in the UK to accept a one-off gene therapy for spinal muscular atrophy.

I refer the member to the answer to question S6W-22774 on 21 November 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The other two medicines alluded to in that answer are Orkambi ® , and Symkevi ® .

If any cystic fibrosis medicine is not recommended in the final multiple technology appraisal (MTA) guidance, clinicians in Scotland will be able to request the use of that medicine on a case-by-case basis for individual patients using the Peer Approved Clinical System (PACS) Tier Two process. National guidance explicitly states that Health Boards should not take account of the cost of medicines when considering applications using the PACS Tier Two system.

Agreed budget savings were announced as part of the Deputy First Minister’s Statement to the Scottish Parliament on 21 November 2023. Further details of savings were included in the ‘Update on 2023-24 In-Year Budget Changes - Letter of 21 November 2023,’ sent to the Finance and Public Administration Committee convenor Kenneth Gibson MSP. A copy of this letter can be found here

We recognise the importance of timely access to speech and language therapy. We have increased the flexibility Health Boards have in reducing waiting times, ensuring those with greatest need are seen first, while maximising prevention and early intervention approaches for those waiting. The number of Speech and Language Therapists working in the NHS has also increased by 1.9% (September 2022 - September 2023), this increased staffing will support reduction of waiting times for this service.

‎Also, Scottish Government's Best Start - strategic early learning and school age childcare plan 2022 to 2026, outlined a commitment to invest in work to support early intervention in speech and language. As part of that work six Full Time Equivalent Regional Leads for Early Years Speech and Language have been recruited – in collaboration with Education Scotland.

The leads are based in each region in Scotland, aligned to Regional Improvement Collaboratives. This will improve outcomes for children’s speech and language across Scotland, by setting up new stakeholder networks, supporting frontline staff, promoting quality improvement and learning from best practice.

While the Scottish Government provides the policies, frameworks and resources for high quality healthcare, it is for each NHS Board to decide best how to utilise funding, facilities and staff while taking account of national and local priorities to meet local health needs. We expect NHS Boards to plan their facilities and workforce to deliver these services, ensuring the provision of safe, effective and high quality patient care, delivered by the right professional at the right time.

The total cost of non-domestic rates relief policies depends on other decisions taken in the Scottish Budget including the Basic, Intermediate and Higher Property Rates. Decisions on non-domestic rates for 2024-2025, including the Property Rates, will be announced in the Scottish Budget 2024-2025 on 19 December 2023.

To measure the effectiveness of the Take Hold Marketing campaign, the paid-for-media marketing campaign will be evaluated.

Pre and post campaign qualitative evaluation is conducted by an independent research company, with a representative sample of the target audience of parents, to measure changes in attitudes and behaviours on seeing and engaging with the campaign. In addition a short survey will be shared with schools to evaluate the use and effectiveness of materials provided to them.

Digital metrics will also be used to gauge the impact of the campaign, including but not limited to, numbers of visits to the NHS Inform vaping pages, visits to Parent Club vaping pages, numbers of click throughs from social media and digital advertising and numbers watching campaign digital videos through to completion.